ACEP26
Powerful Medical will be exhibiting on the show floor. Stop by our booth to see PMcardio in action and learn how emergency departments are using AI to detect acute coronary occlusion that standard STEMI criteria miss.
Chicago, Illinois, USA
October 5–8, 2026
ACEP's Scientific Assembly is the world's largest emergency medicine educational conference. Each year it brings together the global emergency medicine community — over 8,000 attendees from more than 77 countries, 150+ speakers and around 350 exhibitors — for four days of clinical updates, hands-on workshops, professional development and celebration of the specialty.
ACEP26 returns to Chicago with a programme built around the core pillars of emergency medicine: diagnostics, resuscitation and advocacy. The opening general session on 5 October features ACEP President Ryan Stanton's first presidential address and a live conversation with NASA astronaut and emergency physician Dr. Anil Menon from the International Space Station.
- Venue: McCormick Place Convention Center, 2301 S. Dr. Martin Luther King Jr. Drive, Chicago, Illinois, USA
- Organiser: American College of Emergency Physicians (ACEP)
- Website: acep.org
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.